Related Experiment Video
Updated: Aug 16, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
Vitamin E therapy in retinopathy of prematurity
1Institute of Child Health, London.
Insights
Vitamin E, an antioxidant, may help premature infants
Area of Science:
- Neonatal medicine
- Ophthalmology
- Nutritional science
Background:
- Premature infants are vulnerable to oxidative stress.
- Retinopathy of prematurity (ROP) is a serious condition affecting premature infants' eyes.
- Vitamin E is a known antioxidant that scavenges free radicals.
Purpose of the Study:
- To critically review the use of vitamin E for retinopathy of prematurity (ROP).
- To evaluate the risk-benefit relationship of prophylactic vitamin E in premature infants.
Main Methods:
- Literature review of existing trials on vitamin E and ROP.
- Analysis of the evidence regarding prophylactic vitamin E supplementation.
- Assessment of the safety and efficacy of vitamin E in this population.
Main Results:
- The role of prophylactic vitamin E in ROP management remains controversial.
- Evidence supporting its routine use is inconclusive despite numerous studies.
- The risk-benefit profile requires careful consideration.
Conclusions:
- Prophylactic vitamin E supplementation for ROP is not definitively established.
- Further research may be needed to clarify its role.
- Clinical decisions should weigh potential benefits against risks in premature infants.
Abstract:
Vitamin E is a fat soluble antioxidant and as a result it is able to scavenge free radicals derived from oxygen. The premature infant and the retina are likely to be particularly vulnerable to the deleterious effects of these oxygen derived free radicals, and as a result prophylactic vitamin E has been suggested for the management of retinopathy of prematurity (ROP). However, despite numerous trials, prophylactic supplementation with vitamin E remains controversial. This paper will critically review the use of vitamin E in ROP and consider the risk/benefit relationship of such treatment in premature infants.

